Armata Pharmaceuticals Updates Chief Medical Officer’s Compensation
Company Announcements

Armata Pharmaceuticals Updates Chief Medical Officer’s Compensation

Armata Pharmaceuticals (ARMP) has shared an update.

Mina Pastagia, M.D., has amended her employment terms with Armata Pharmaceuticals, reflecting her role as Chief Medical Officer since January 2023 and a base salary of $456,800. Starting in fiscal year 2024, she’s set for a 50% target annual bonus based on performance, with the potential for additional equity grants beginning in 2025. Should her employment end without cause or for good reason, she’s entitled to a year’s salary continuation, provided she adheres to certain conditions post-termination.

Learn more about ARMP stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskArmata Pharmaceuticals Extends Credit Agreement and CMO Departs
TheFlyArmata Pharmaceuticals reports Q3 EPS (15c) vs. (86c) last year
TipRanks Auto-Generated NewsdeskArmata Completes Enrollment for Innovative Bacteriophage Study
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App